نتائج البحث - "Schreurs, A.J.M."

1

Academic Journal

Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease

المؤلفون: van den Berge, M., Hop, W.C.J., van der Molen, T., van Noord, J.A., Creemers, J.P.H.M., Schreurs, A.J.M., Wouters, E.F.M., Postma, D.S., the COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization), study group

المصدر: van den Berge , M , Hop , W C J , van der Molen , T , van Noord , J A , Creemers , J P H M , Schreurs , A J M , Wouters , E F M , Postma , D S & the COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) , S G 2012 , ' Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease ' , Respiratory Research , vol. 13 , 44 . https://doi.org/10.1186/1465-9921-13-44

الاتاحة: https://cris.maastrichtuniversity.nl/en/publications/fcffa888-63b5-4c6e-8902-5f6d8eeb3fd8
https://doi.org/10.1186/1465-9921-13-44

View record in BASE

2

Academic Journal

Zoledronic acid in patients with stage IIIA/B NSCLC: results of a randomized, phase III study

المؤلفون: Scagliotti, G.V., Kosmidis, P., de Marinis, F., Schreurs, A.J.M., Albert, I., Engel-Riedel, W., Schallier, D., Barbera, S., Kuo, H.-P., Sallo, V., Perez, J.R., Manegold, C.

المساهمون: Novartis Pharmaceuticals Corporation

المصدر: Annals of Oncology ; volume 23, issue 8, page 2082-2087 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1093/annonc/mds128
https://api.elsevier.com/content/article/PII:S092375341938127X?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S092375341938127X?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/23/8/2082/13788732/mds128.pdf

View record in BASE

3

Academic Journal

Safety, tolerability and efficacy of indacaterol, a novel once-daily β-agonist, in patients with COPD: A 28-day randomised, placebo controlled clinical trial

المؤلفون: Beier, Jutta, Chanez, Pascal, Martinot, J.-B. Jean-Benoit, Schreurs, A.J.M., Tkáčová, R. Ružena, Bao, Weibin, Jack, Damon, Higgins, Mark

المساهمون: insaf Respiratory Research Institute, Human Computer Technology Laboratory (HCTLab), Universidad Autonoma de Madrid (UAM), Department of Pneumology and Tuberculosis, Faculty Hospital L. Pasteur, Novartis Horsham Research Centre

المصدر: Pulmonary Pharmacology & Therapeutics ; https://hal.archives-ouvertes.fr/hal-00499139 ; Pulmonary Pharmacology & Therapeutics, 2007, 20 (6), pp.740. ⟨10.1016/j.pupt.2006.09.001⟩

مصطلحات موضوعية: Medicine

Relation: hal-00499139; https://hal.archives-ouvertes.fr/hal-00499139; https://hal.archives-ouvertes.fr/hal-00499139/document; https://hal.archives-ouvertes.fr/hal-00499139/file/PEER_stage2_10.1016%252Fj.pupt.2006.09.001.pdf

الاتاحة: https://hal.archives-ouvertes.fr/hal-00499139
https://hal.archives-ouvertes.fr/hal-00499139/document
https://hal.archives-ouvertes.fr/hal-00499139/file/PEER_stage2_10.1016%252Fj.pupt.2006.09.001.pdf
https://doi.org/10.1016/j.pupt.2006.09.001

View record in BASE

4

Safety, tolerability and efficacy of indacaterol, a novel once-daily β-agonist, in patients with COPD: A 28-day randomised, placebo controlled clinical trial

المؤلفون: Beier , Jutta, Chanez , Pascal, Martinot , J.-B. Jean-Benoit, Schreurs , A.J.M., Tkáčová , R. Ružena, Bao , Weibin, Jack , Damon, Higgins , Mark

المساهمون: insaf Respiratory Research Institute, Human Computer Technology Laboratory ( HCTLab ), Universidad Autonoma de Madrid ( UAM ), Department of Pneumology and Tuberculosis, Faculty Hospital L. Pasteur, Novartis Horsham Research Centre

المصدر: Pulmonary Pharmacology & Therapeutics
Pulmonary Pharmacology & Therapeutics, 2007, 20 (6), pp.740. 〈10.1016/j.pupt.2006.09.001〉

مصطلحات موضوعية: Medicine, ComputingMilieux_MISCELLANEOUS

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f4a9be3b145568b58e6b808234457428
https://hal.archives-ouvertes.fr/hal-00499139/file/PEER_stage2_10.1016%2Fj.pupt.2006.09.001.pdf

View record in OpenAIRE